These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1949214)

  • 1. Sustained release of isoniazid in vivo from a single implant of a biodegradable polymer.
    Gangadharam PR; Ashtekar DR; Farhi DC; Wise DL
    Tubercle; 1991 Jun; 72(2):115-22. PubMed ID: 1949214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental chemotherapy of tuberculosis using single dose treatment with isoniazid in biodegradable polymers.
    Gangadharam PR; Kailasam S; Srinivasan S; Wise DL
    J Antimicrob Chemother; 1994 Feb; 33(2):265-71. PubMed ID: 8182007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide.
    Gangadharam PR; Geeta N; Hsu YY; Wise DL
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):515-20. PubMed ID: 10383065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of therapeutically active levels of isoniazid for prolonged periods in rabbits after a single implant of biodegradable polymer.
    Kailasam S; Daneluzzi D; Gangadharam PR
    Tuber Lung Dis; 1994 Oct; 75(5):361-5. PubMed ID: 7841429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles.
    Dutt M; Khuller GK
    J Antimicrob Chemother; 2001 Jun; 47(6):829-35. PubMed ID: 11389115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis.
    Dutt M; Khuller GK
    Int J Antimicrob Agents; 2001 Feb; 17(2):115-22. PubMed ID: 11165115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
    Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
    J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and chemotherapeutic activity of clofazimine against Mycobacterium avium complex infections in beige mice following a single implant of a biodegradable polymer.
    Kailasam S; Wise DL; Gangadharam PR
    J Antimicrob Chemother; 1994 Feb; 33(2):273-9. PubMed ID: 8182008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of Poly(DL-lactide-Co-Glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice.
    Dutt M; Khuller GK
    Antimicrob Agents Chemother; 2001 Jan; 45(1):363-6. PubMed ID: 11121000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
    Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH
    Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices.
    Hsu YY; Gresser JD; Trantolo DJ; Lyons CM; Gangadharam PR; Wise DL
    J Biomed Mater Res; 1997 Apr; 35(1):107-16. PubMed ID: 9104703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix.
    Woo BH; Fink BF; Page R; Schrier JA; Jo YW; Jiang G; DeLuca M; Vasconez HC; DeLuca PP
    Pharm Res; 2001 Dec; 18(12):1747-53. PubMed ID: 11785696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis.
    Pandey R; Zahoor A; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2003; 83(6):373-8. PubMed ID: 14623168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
    Wang G; Tucker IG; Roberts MS; Hirst LW
    Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release behavior of poly(lactic acid-co-glycolic acid) implants containing phosphorothioate oligodeoxynucleotide.
    Yamakawa I; Ishida M; Kato T; Ando H; Asakawa N
    Biol Pharm Bull; 1997 Apr; 20(4):455-9. PubMed ID: 9145231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins.
    Eliaz RE; Kost J
    J Biomed Mater Res; 2000 Jun; 50(3):388-96. PubMed ID: 10737881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of implant tablet for a week-long sustained release.
    Takahashi M; Onishi H; Machida Y
    J Control Release; 2004 Nov; 100(1):63-74. PubMed ID: 15491811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model.
    Suarez S; O'Hara P; Kazantseva M; Newcomer CE; Hopfer R; McMurray DN; Hickey AJ
    Pharm Res; 2001 Sep; 18(9):1315-9. PubMed ID: 11683246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections.
    Benoit MA; Mousset B; Delloye C; Bouillet R; Gillard J
    Int Orthop; 1997; 21(6):403-8. PubMed ID: 9498152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.